Arcadia Biosciences (FRA:17D) Cash per Share: €1.66 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:17D Arcadia Biosciences Inc FRA:17D
42 GF Score
Price €3.72
GF Value €17.19
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences Cash per Share?

Arcadia Biosciences FRA:17D 42 Cash per Share is €1.66 as of Jun. 2026. GuruFocus rates FRA:17D with a GF Score™ of 42/100 and a GF Value™ of €17.19. The stock has 4 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Arcadia Biosciences's Cash per Share for the quarter that ended in Jun. 2026 was €1.66.

Arcadia Biosciences  (FRA:17D) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Arcadia Biosciences Cash per Share Related Terms

Arcadia Biosciences Cash per Share Historical Data

* Premium members only.

The historical data trend for Arcadia Biosciences's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences Cash per Share Chart

Arcadia Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.74 31.64 8.31 2.97 2.84

Arcadia Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.82 3.67 2.84 1.56 1.66
FRA:17D
42GF Score
Arcadia Biosciences Inc FRA:17D
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcadia Biosciences Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Arcadia Biosciences's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=3.897/1.37
=2.84

Arcadia Biosciences's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=3.627/2.18
=1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of €1.66 mean?
Arcadia Biosciences (FRA:17D) has a Cash per Share of €1.66 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Arcadia Biosciences and its competitors.
Is Arcadia Biosciences' Cash per Share too high?
Arcadia Biosciences' current Cash per Share is €1.66. Overall, Arcadia Biosciences has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Cash per Share compare to HIGR and SNBH?
Arcadia Biosciences' Cash per Share of €1.66 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Consumer Packaged Goods company?
A good Cash per Share depends on the Consumer Packaged Goods industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Arcadia Biosciences and its competitors. Arcadia Biosciences's current Cash per Share is €1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Arcadia Biosciences (FRA:17D) has a current Cash per Share of €1.66. The stock's GF Value™ is €17.19, compared to a current price of €3.72 — trading 78.4% below its estimated fair value. The current Cash per Share is €1.66. Arcadia Biosciences' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Arcadia Biosciences (FRA:17D), the current Cash per Share is €1.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcadia Biosciences (FRA:17D) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of €3.72 is trading 78.4% below its estimated GF Value™ of €17.19.

Key valuation signals for FRA:17D:

  • Cash per Share: €1.66
  • GF Value™: €17.19 vs. price of €3.72 (78.4% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the FRA:17D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcadia Biosciences Business Description

Other Exchanges RKDA:USA
Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
42GF Score

Get the complete analysis for FRA:17D

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€17.19
GF Value